LINC02772

Across TCGA pan-cancer cohorts, LINC02772 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of LINC02772’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC02772 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02772 is over-expressed in tumor, although a few such as LUAD and KIRC show the opposite, repressed pattern.

LUAD, KIRC, and KIRP are the cancer types where LINC02772 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02772 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	III,IV	−2.188	<.001	11	view →
KIRC	Female	All	−0.430	<.001	11	view →
KIRP	All	II,III,IV	−0.250	<.001	11	view →
LUSC	All	II,III,IV	−1.620	<.001	7	view →
KICH	All	All	+0.953	<.001	6	view →
COAD	All	All	+0.175	.012	3	view →
READ	All	III,IV	+0.385	.041	2	view →
THCA	All	IV	−0.277	.001	2	view →
BLCA	Male	All	−0.165	.041	2	view →
STAD	All	All	+0.162	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

LINC02772–LUAD

Open the LUAD breakdown →